Cart
sales@molnova.com
Vinaginsenoside R4
CAS No. 156009-80-2
Vinaginsenoside R4( —— )
Catalog No. M23675 CAS No. 156009-80-2
Vinaginsenoside R4 has melanogenic inhibitory activity, it may have potential as a new skin whitening compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 373 | In Stock |
|
| 5MG | 432 | In Stock |
|
| 10MG | 622 | In Stock |
|
| 25MG | 938 | In Stock |
|
| 50MG | 1265 | In Stock |
|
| 100MG | 1702 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVinaginsenoside R4
-
NoteResearch use only, not for human use.
-
Brief DescriptionVinaginsenoside R4 has melanogenic inhibitory activity, it may have potential as a new skin whitening compound.
-
DescriptionVinaginsenoside R4 has melanogenic inhibitory activity, it may have potential as a new skin whitening compound.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptormelanogenic?
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number156009-80-2
-
Formula Weight963.16
-
Molecular FormulaC48H82O19
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 16.67 mg/mL (17.31 mM)
-
SMILESC[C@]12[C@@](C[C@@H](O)[C@@]3([H])[C@]2(CC[C@]3([H])[C@@](CCC=C(C)C)(C)O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)CO)C)([H])[C@@]5([C@@](C(C)([C@@H](O[C@@]6([H])[C@@H]([C@H]([C@H](O)[C@@H](CO)O6)O)O[C@]7([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)CO)CC5)C)([H])[C@@H](O)C1)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.The potential of minor ginsenosides isolated from the leaves of Panax ginseng as inhibitors of melanogenesis.Int J Mol Sci. 2015 Jan 13;16(1):1677-90.
molnova catalog
related products
-
Propargyl-PEG13-brom...
Propargyl-PEG13-bromide is a PEG derivative containing a propargyl group.
-
ML265
ML265 is a potent PKM2 activator (AC50 : 92 nM) showing little or no effect on PKM1 PKL and PKRinduces tetramerization and reduces tumor formation and size in a mouse xenograft model.?.
-
β-Amyloid/A4 Protein...
β-Amyloid/A4 Protein Precusor (319-335) (APP (319-335)) is a peptide fragment of β-Amyloid/A4 protein precursor (APP). β-Amyloid/A4 Protein Precusor (319-335) can recognize the heparinase-insensitive site that contains the neuritotropic activity of APP.
